Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Adomat

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Scientific Reports|February 24, 2022
Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cellsChris Kedong Wang, Irina Nelepcu, Desmond Hui, et al.
Chemistry & Biology|December 3, 2014
Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancerRavi S N Munuganti, Mohamed D H Hassona, Eric Leblanc, et al.
Frontiers in Molecular Biosciences|April 19, 2021
A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic StrokeBrett A Eyford, Chaahat S B Singh, Thomas Abraham, et al.
Frontiers in Molecular Biosciences|May 24, 2021
Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic StrokeBrett A Eyford, Chaahat S B Singh, Thomas Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing SarcomaLouise Ramos, Sarah Truong, Beibei Zhai, et al.
Journal of the National Cancer Institute|May 28, 2010
Effect of noncompetitive proteasome inhibition on bortezomib resistanceXiaoming Li, Tabitha E Wood, Remco Sprangers, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Cancers|September 10, 2021
Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung CancerHtoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, et al.
Cell Reports|April 5, 2025
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 24, 2022
Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cellsChris Kedong Wang, Irina Nelepcu, Desmond Hui, et al.
Chemistry & Biology|December 3, 2014
Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancerRavi S N Munuganti, Mohamed D H Hassona, Eric Leblanc, et al.
Frontiers in Molecular Biosciences|April 19, 2021
A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic StrokeBrett A Eyford, Chaahat S B Singh, Thomas Abraham, et al.
Frontiers in Molecular Biosciences|May 24, 2021
Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic StrokeBrett A Eyford, Chaahat S B Singh, Thomas Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing SarcomaLouise Ramos, Sarah Truong, Beibei Zhai, et al.
Journal of the National Cancer Institute|May 28, 2010
Effect of noncompetitive proteasome inhibition on bortezomib resistanceXiaoming Li, Tabitha E Wood, Remco Sprangers, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancerBetul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Cancers|September 10, 2021
Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung CancerHtoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, et al.
Cell Reports|April 5, 2025
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Pageof 7